These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 93426)

  • 21. Decreased prostatic secretory function in canine benign prostatic hyperplasia is not due to decreased levels of muscarinic cholinergic receptors.
    Lepor H; Berry SJ
    J Urol; 1984 Apr; 131(4):803-5. PubMed ID: 6200613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphotyrosine antibodies preferentially react with basal epithelial cells in the dog prostate.
    Landry F; Chapdelaine A; Bégin LR; Chevalier S
    J Urol; 1996 Jan; 155(1):386-90. PubMed ID: 7490893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of aromatase inhibitor, TZA-2209, on the prostate of androstenedione-treated castrated dogs: changes in prostate volume and histopathological findings.
    Suzuki K; Ito K; Tamura Y; Suzuki T; Honma S; Yamanaka H
    Prostate; 1996 May; 28(5):328-37. PubMed ID: 8610061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unusual prostatic mass in a dog.
    Gilson SD; Miller RT; Hardie EM; Spaulding KA
    J Am Vet Med Assoc; 1992 Mar; 200(5):702-4. PubMed ID: 1373709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical Expression of Angiogenic Factors by Neoplastic Epithelial Cells Is Associated With Canine Prostatic Carcinogenesis.
    Palmieri C
    Vet Pathol; 2015 Jul; 52(4):607-13. PubMed ID: 25281650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphometric analysis of prostates in castrated dogs after treatment with androstanediol, estradiol, and cyproterone acetate.
    Tunn UW; Schüring B; Senge T; Neumann F; Schweikert HU; Rohr HP
    Invest Urol; 1981 Jan; 18(4):289-92. PubMed ID: 6161104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effect of the aromatase inhibitor, anastrazole, to the antioestrogen, tamoxifen citrate, on canine prostate and semen.
    Gonzalez G; Guendulain C; Maffrand C; Gobello C
    Reprod Domest Anim; 2009 Jul; 44 Suppl 2():316-9. PubMed ID: 19754594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of androgen, oestrogen alpha and beta, and progesterone receptors in the canine prostate: differences between normal, inflamed, hyperplastic and neoplastic glands.
    Gallardo F; Mogas T; Baró T; Rabanal R; Morote J; Abal M; Reventós J; Lloreta J
    J Comp Pathol; 2007 Jan; 136(1):1-8. PubMed ID: 17078963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testicular androgen and estrogen secretion and benign prostatic hyperplasia in the beagle.
    Ewing LL; Thompson DL; Cochran RC; Lasley BL; Thompson MA; Zirkin BR
    Endocrinology; 1984 Apr; 114(4):1308-14. PubMed ID: 6200316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of osaterone acetate administration on prostatic regression rate, peripheral blood hormone levels and semen quality in dogs with benign prostatic hypertrophy.
    Tsutsui T; Hori T; Shimizu M; Tatsuzawa C; Kawakami E
    J Vet Med Sci; 2001 Apr; 63(4):453-6. PubMed ID: 11346183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-related changes in the prostate and testes of the beagle dog.
    Lowseth LA; Gerlach RF; Gillett NA; Muggenburg BA
    Vet Pathol; 1990 Sep; 27(5):347-53. PubMed ID: 1700534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of two sample collection methods for quantitative bacteriologic culture of canine prostatic fluid.
    Ling GV; Nyland TG; Kennedy PC; Hager DA; Johnson DL
    J Am Vet Med Assoc; 1990 May; 196(9):1479-82. PubMed ID: 2187840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in semen quality and morphology of the reproductive tract of the male tammar wallaby parallel seasonal breeding activity in the female.
    Paris DB; Taggart DA; Shaw G; Temple-Smith PD; Renfree MB
    Reproduction; 2005 Sep; 130(3):367-78. PubMed ID: 16123244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A noninvasive technique for monitoring changes in canine prostatic size in vivo.
    Wade DR; Pirmann JC; Winter ML; Falvo RE
    Invest Urol; 1981 Jan; 18(4):266-9. PubMed ID: 6161103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative and total volume of histological components in benign prostatic hyperplasia: relationships between histological components and clinical findings.
    Ishigooka M; Hayami S; Hashimoto T; Suzuki Y; Katoh T; Nakada T
    Prostate; 1996 Aug; 29(2):77-82. PubMed ID: 8700803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of prostate hyperplasia.
    Venn AC
    Vet Rec; 1970 Jan; 86(4):112. PubMed ID: 4189461
    [No Abstract]   [Full Text] [Related]  

  • 37. Holmium laser enucleation of the prostate--outcomes independent of prostate size?
    Humphreys MR; Miller NL; Handa SE; Terry C; Munch LC; Lingeman JE
    J Urol; 2008 Dec; 180(6):2431-5; discussion 2435. PubMed ID: 18930490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Reduction of the weight of prostatic tissue during transurethral resection].
    Alkhouja AS; Gazaigne J
    Prog Urol; 1997 Feb; 7(1):48-50. PubMed ID: 9116738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of an extract of Serenoa repens on dogs with hyperplasia of the prostate gland.
    Barsanti JA; Finco DR; Mahaffey MM; Fayrer-Hosken RA; Crowell WA; Thompson FN; Shotts EB
    Am J Vet Res; 2000 Aug; 61(8):880-5. PubMed ID: 10951976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathological changes of benign hyperplastic prostate after removal of innervation of cholinergic pelvic nerve: experiment with spontaneous hypertension rats].
    Cai JL; Xin DQ; He Q; Tang XQ; Na YQ
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(18):1284-8. PubMed ID: 18844105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.